BNKK
Bonk, Inc.
There isn't enough reported data to score BNKK yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
BNKK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Unavailable | |
| Unavailable |
BNKK's revenue is currently strong, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BNKK PE Valuation
BNKK has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BNKK Forward outlook
There aren't enough analyst estimates for BNKK to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BNKK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$18.36 | -$4.01 |
| Q1 2026 | -$14.45 | +$8.65 |
| Q4 2025 | -$17.02 | +$14.83 |
| Q3 2025 | -$14.70 | +$15.75 |
| Q2 2025 | -$14.35 | +$17.85 |
| Q1 2025 | -$23.10 | +$3.85 |
| Q4 2024 | -$31.85 | -$14.70 |
| Q3 2024 | -$30.45 | -$5.60 |
BNKK is still losing money, but far less than before: $18.36 per share over the past year, against $59.15 at its worst in late 2021.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BNKK on earnings quality, reporting a profit while its opponent remains loss making.
BNKK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $792.9K | +1664% |
| Q1 2026 | $786.3K | +1768% |
| Q4 2025 | $515.4K | +183% |
| Q3 2025 | $1.5M | +1274% |
| Q2 2025 | $44.9K | -94% |
| Q1 2025 | $42.1K | -75% |
| Q4 2024 | $182.2K | +37% |
| Q3 2024 | $110.2K | +828% |
BNKK has the edge over CELH on sales, with stronger typical year-over-year growth.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
BNKK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$848K | +$4.7M |
| Q3 2024 | -$5.2M | -$2.2M |
| Q1 2024 | -$6.4M | -$4.9M |
| Q4 2023 | -$5.5M | -$3.9M |
| Q3 2023 | -$3M | -$1.9M |
| Q2 2023 | -$682.6K | +$326.3K |
| Q1 2023 | -$1.5M | +$1.2M |
| Q4 2022 | -$1.6M | +$929.2K |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with BNKK at down 0.1%.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BNKK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +98.3K shares |
| 1 year | +305% | +6M shares |
| 3 years | +1203% | +7.4M shares |
BNKK has 8M diluted shares, up 305% from a year ago.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over BNKK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BNKK Net Leverage
BNKK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BNKK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.0 | Neutral |
| Stochastic | 8.9 | Oversold |
BNKK's weekly RSI is 35 (neutral) and its Stochastic is 9 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BNKK PE vs Consumer Defensive Sector
BNKK has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BNKK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.25 | 26% below |
| 20 week MA | $1.23 | 25% below |
| 50 week MA | $2.32 | 60% below |
| 100 week MA | $9.03 | 90% below |
| 200 week MA | $28.4 | 97% below |
BNKK is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over BNKK on trend strength, trading above more of its moving averages.
BNKK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $149.1 | $177.1 | +19% |
| 2021 | $177.1 | $33.4 | -81% |
| 2022 | $33.4 | $27.2 | -19% |
| 2023 | $27.2 | $122.9 | +352% |
| 2024 | $122.9 | $26.9 | -78% |
| 2025 | $26.9 | $2.99 | -89% |
| 2026 YTD | $2.99 | $0.92 | -69% |
BNKK's yearly returns have swung widely, from +352% in 2023 to −89% in 2025. It's down 69% so far in 2026.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over BNKK on returns for 2026, with the stronger performance.